Rapid detection of microorganism resistance in patients with ventilator-associated pneumonia

Clinical Pulmonary Medicine

Volumn 16, Issue 6, 2009, Pages 302-308

  Muñoz, Patricia ^a   Cercenado, Emilia ^a   Giannella, Maddalena ^a   Bouza, Emilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Antimicrobial use; E test; Gram stain; Microbiological diagnosis; Resistance detection; Ventilatory associated pneumonia

Indexed keywords

AMIKACIN; ANTIINFECTIVE AGENT; CEFEPIME; CIPROFLOXACIN; IMIPENEM; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC SENSITIVITY; ARTIFICIAL VENTILATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BROTH DILUTION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; DRUG UTILIZATION; EPSILOMETER TEST; GENEXPERT ASSAY; HUMAN; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; MICROBIAL COLONIZATION; MICROBIOLOGICAL EXAMINATION; MICROORGANISM DETECTION; POLYMERASE CHAIN REACTION; REVIEW; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 74549195034     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/CPM.0b013e3181be0198     Document Type: Review

References (44)

1. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
2. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165:867-903.
3. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122: 2115-2121.
4. Kollef KE, Schramm GE, Wills AR, et al. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest. 2008;134:281-287.
5. Cabello H, Torres A, Celis R, et al. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur Respir J. 1997;10:1137-1144. (Pubitemid 27201822)
6. Markowicz P, Wolff M, Djedaini K, et al. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group. Am J Respir Crit Care Med. 2000;161:1942-1948.
7. Fagon JY, Chastre J, Hance AJ, et al. Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993;94:281-288.
8. Diaz E, Munoz E, Agbaht K, et al. Management of ventilator-associated pneumonia caused by multiresistant bacteria. Curr Opin Crit Care. 2007;13:45-50.
9. Garnacho-Montero J, Ortiz-Leyba C, Fernandez-Hinojosa E, et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings. Intensive Care Med. 2005;31:649-655.
10. Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin Infect Dis. 2000;31:S131-S138.
11. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998;157:531-539.
12. Fagon JY, Chastre J, Hance AJ, et al. Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest. 1993;103:547-553.
13. Fabregas N, Ewig S, Torres A, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate postmortem lung biopsies. Thorax. 1999;54:867-873.
14. Wunderink RG, Woldenberg LS, Zeiss J, et al. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest. 1992;101:458-463.
15. Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med. 2000;162:505-511.
16. Sterling TR, Ho EJ, Brehm WT, et al. Diagnosis and treatment of ventilatorassociated pneumonia-impact on survival. A decision analysis. Chest. 1996; 110:1025-1034.
17. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator- associated pneumonia: a pilot study. Am J Respir Crit Care Med. 1998;157:371-376.
18. Ruiz M, Torres A, Ewig S, et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia: evaluation of outcome. Am J Respir Crit Care Med. 2000;162:119-125.
19. Sole Violan J, Fernandez JA, Benitez AB, et al. Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med. 2000; 28:2737-2741.
20. Fagon JY, Chastre J, Wolff M, et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. A randomized trial. Ann Intern Med. 2000;132:621-630.
21. Shorr AF, Sherner JH, Jackson WL, et al. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med. 2005;33:46-53.
22. Fartoukh M, Maitre B, Honore S, et al. Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited. Am J Respir Crit Care Med. 2003;168:173-179.
23. Torres A, Aznar R, Gatell JM, et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990;142:523-528.
24. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290:2588-2598.
25. Craig CP, Connelly S. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality. Am J Infect Control. 1984;12:233-238.
26. Cunha BA. Nosocomial pneumonia. Diagnostic and therapeutic considerations. Med Clin North Am. 2001;85:79-114.
27. Dupont H, Mentec H, Sollet JP, et al. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med. 2001;27:355-362.
28. Fagon JY, Chastre J, Vuagnat A, et al. Nosocomial pneumonia and mortality among patients in intensive care units. JAMA. 1996;275:866-869.
29. Safdar N, Dezfulian C, Collard HR, et al. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med. 2005;33:2184-2193.
30. Kollef MH. Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems. Respir Care. 2004;49:1530-1541.
31. Rello J, Vidaur L, Sandiumenge A, et al. De-escalation therapy in ventilatorassociated pneumonia. Crit Care Med. 2004;32:2183-2190.
32. Salata RA, Lederman MM, Shlaes DM, et al. Diagnosis of nosocomial pneumonia in intubated, intensive care unit patients. Am Rev Respir Dis. 1987;135:426-432.
33. Laupland KB, Church DL, Gregson DB. Validation of a rapid diagnostic strategy for determination of significant bacterial counts in bronchoalveolar lavage samples. Arch Pathol Lab Med. 2005;129:78-81.
34. Cercenado E, Cercenado S, Marin M, et al. Evaluation of direct E-test on lower respiratory tract samples: a rapid and accurate procedure for antimicrobial susceptibility testing. Diagn Microbiol Infect Dis. 2007;58:211-216.
35. Bouza E, Torres MV, Radice C, et al. Direct E-test (AB Biodisk) of respiratory samples improves antimicrobial use in ventilator-associated pneumonia. Clin Infect Dis. 2007;44:382-387.
36. Rossney AS, Herra CM, Brennan GI, et al. Evaluation of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay using the GeneXpert real-time PCR platform for rapid detection of MRSA from screening specimens. J Clin Microbiol. 2008;46:3285-3290.
37. Huang MB, Baker CN, Banerjee S, et al. Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J Clin Microbiol. 1992;30:3243-3248.
38. Trenholme GM, Kaplan RL, Karakusis PH, et al. Clinical impact of rapid identification and susceptibility testing of bacterial blood culture isolates. J Clin Microbiol. 1989;27:1342-1345.
39. Zebouh M, Thomas C, Honderlick P, et al. Evaluation of a new E-test method for antimicrobial sensitivity testing of Pseudomonas aeruginosa isolates from cystic fibrosis. Pathol Biol (Paris). 2005;53:490-494.
40. Hengstler KA, Hammann R, Fahr AM. Evaluation of BBL CHROMagar orientation medium for detection and presumptive identification of urinary tract pathogens. J Clin Microbiol. 1997;35:2773-2777.
41. Perry JD, Rennison C, Butterworth LA, et al. Evaluation of S. aureus ID, a new chromogenic agar medium for detection of Staphylococcus aureus. J Clin Microbiol. 2003;41:5695-5698.
42. Murdoch DR. Nucleic acid amplification tests for the diagnosis of pneumonia. Clin Infect Dis. 2003;36:1162-1170.
43. Xpert MRSA-package insert-. Sunnyvale, CA: Cepheid; 2007.
44. Marlowe E, Wolk D. GeneXpert testing: applications for clinical microbiology, Part I. Clin Microbiol Newsl. 2008;30:175-179.